Australia’s mental health system continues to face rising demand, with nearly half the population expected to experience a mental health condition in their lifetime. Access to specialist care for complex conditions like treatment-resistant depression and PTSD remains limited, often constrained by cost and availability. Emyria Limited (ASX:EMD) is targeting this gap by expanding insurer-backed treatment
Read More
Following a highly competitive tender process, medical distribution company BTC Health (ASX: BTC) has secured a $5 million contract with the Royal Children’s Hospital (RCH), continuing a run of successes since undertaking a business transformation 12 months ago to diversify its product portfolio. This five-year RCH contract marks the first implementation of the Eurosets ECMOLIFE
Read More
It turns out that the departure of a significant partner can be a blessing in disguise, as demonstrated by medical distribution company BTC Health (ASX: BTC), which has delivered revenue and earnings growth through a series of measures implemented through FY24 to reduce their reliance on their previously biggest supplier. In April 2023, BTC confirmed
Read More
Dental products manufacturer SDI Limited (ASX: SDI), has announced an uplift in expected profit for FY24, following a range of operational initiatives announced four months ago to reduce operating expenses. SDI’s preliminary sales for FY24 (unaudited) revealed a 3.2% increase to $111.4 million, compared to $107.9 million in the previous year, marking a record twelve-month
Read More
Despite the challenging economic landscape, Australians continue to prioritise their dental health, as evidenced by Pacific Smiles Group‘s (ASX: PSQ) which has reported a notable increase in patient fees, underscoring the resilience of the dental care sector amidst cost of living pressures. Pacific Smiles disclosed a significant rise in patient fees, which reached $285.4 million
Read More
Pharmaceutical and healthcare company Vita Life Sciences (ASX: VLS) has forecasted a positive growth trajectory for the first half of CY24. Besides expecting sales growth, it is also expecting returns from its recent product launch in Vietnam. The Company expects sales to rise to between $39 million and $40 million, up from $34.7 million in
Read More